Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders
23 Mai 2024 - 6:42PM
Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today
announced the results of matters voted on at its annual meeting of
shareholders held on May 23, 2024 (the “Meeting”). The voting
results for each of the matters considered at the Meeting are
presented below.
The total number of common shares represented by
shareholders present in person or by proxy at the Meeting was
31,858,543, representing 38.21% of the Company’s outstanding common
shares.
1. Election of Directors
On a vote by ballot, the election of eight of
the following nine nominees as directors of the Company to hold
office until the next annual meeting of the Company, or until their
respective successors are elected or appointed, was approved. Alan
Hibben did not receive a majority of votes in favour at the Meeting
and thus has not been re-elected as a director of Extendicare and
resigned as such effective at the end of the Meeting. The results
of the vote on this matter are set out below.
Nominee |
Votes For |
% |
Votes Against |
% |
Norma Beauchamp |
31,188,526 |
99.37 |
197,524 |
0.63 |
Dr. Michael Guerriere |
31,204,369 |
99.42 |
181,681 |
0.58 |
Sandra L. Hanington |
30,752,639 |
97.98 |
633,410 |
2.02 |
Alan R. Hibben |
12,943,933 |
41.24 |
18,442,116 |
58.76 |
Brent Houlden |
31,207,781 |
99.43 |
178,269 |
0.57 |
Donna E. Kingelin |
31,148,497 |
99.24 |
237,373 |
0.76 |
Samir Manji |
30,739,166 |
97.94 |
646,884 |
2.06 |
Al Mawani |
30,724,478 |
97.89 |
661,572 |
2.11 |
Alan D. Torrie |
30,295,942 |
96.53 |
1,090,107 |
3.47 |
Alan joined the board of directors of
Extendicare in 2016 and served as a member and chair of various
committees of the board, including as Chair of the Audit Committee.
Alan was steadfastly independent and forthright, but also a
collaborative member who placed the interests of the Company, its
shareholders and those in its care above all else. We wish him well
in his future board roles. The Company will in due course commence
a process to address the vacancy.
2. Appointment of Auditors
On a vote by show of hands, the appointment of
KPMG LLP as the auditors of the Company to hold office until the
close of the next annual meeting of the Company at such
remuneration as shall be fixed by the board of directors of the
Company was approved. The results of the vote on this matter are
set out below.
Votes For |
% |
Votes Withheld |
% |
30,054,828 |
94.37 |
1,793,532 |
5.63 |
3. Approach to Executive
Compensation
On a vote by show of hands, a non-binding
advisory resolution to accept the Company’s approach to executive
compensation disclosed in the Company’s management information and
proxy circular dated April 11, 2024 was approved. The results of
the vote on this matter are set out below.
Votes For |
% |
Votes Against |
% |
30,724,273 |
97.92 |
651,594 |
2.08 |
About Extendicare
Extendicare is a leading provider of care and
services for seniors across Canada, operating under the
Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing
Partner Network brands. We are committed to delivering quality care
throughout the health continuum to meet the needs of a growing
seniors’ population. We operate a network of 123 long-term care
homes (52 owned/71 under management contracts), deliver
approximately 10.2 million hours of home health care services
annually, and provide group purchasing services to third parties
representing approximately 138,300 beds across Canada. Extendicare
proudly employs approximately 22,000 qualified, highly trained and
dedicated team members who are passionate about providing
high-quality care and services to help people live better.
Forward-looking Statements
Information provided by Extendicare from time to
time, including this release, contains or may contain
forward-looking statements concerning anticipated future events,
results, circumstances, economic performance or expectations with
respect to Extendicare and its subsidiaries, including, without
limitation, statements regarding its business operations, business
strategy, growth strategy, results of operations and financial
condition. Forward-looking statements can often be identified by
the expressions “anticipate”, “believe”, “estimate”, “expect”,
“intend”, “objective”, “plan”, “project”, “will”, “may”, “should”
or other similar expressions or the negative thereof. These
forward-looking statements reflect the Company’s current
expectations regarding future results, performance or achievements
and are based upon information currently available to the Company
and on assumptions that the Company believes are reasonable. The
Company assumes no obligation to update or revise any
forward-looking statement, except as required by applicable
securities laws. These statements are not guarantees of future
performance and involve known and unknown risks, uncertainties and
other factors that may cause actual results, performance or
achievements of the Company to differ materially from those
expressed or implied in the statements. Given these risks and
uncertainties, readers are cautioned not to place undue reliance on
Extendicare’s forward-looking statements. Further information can
be found in the disclosure documents filed by Extendicare with the
securities regulatory authorities, available at www.sedarplus.ca
and on Extendicare’s website at www.extendicare.com.
Extendicare contact:
Jillian E. Fountain Vice President, Investor
RelationsT: (905) 470-5534 E:
jfountain@extendicare.comwww.extendicare.com
Extendicare (TSX:EXE)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Extendicare (TSX:EXE)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024